These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 23064662)

  • 1. Bone disease in pediatric chronic kidney disease.
    Wesseling-Perry K
    Pediatr Nephrol; 2013 Apr; 28(4):569-76. PubMed ID: 23064662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease.
    Graciolli FG; Neves KR; Barreto F; Barreto DV; Dos Reis LM; Canziani ME; Sabbagh Y; Carvalho AB; Jorgetti V; Elias RM; Schiavi S; Moysés RMA
    Kidney Int; 2017 Jun; 91(6):1436-1446. PubMed ID: 28318623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The osteocyte in CKD: new concepts regarding the role of FGF23 in mineral metabolism and systemic complications.
    Wesseling-Perry K; Jüppner H
    Bone; 2013 Jun; 54(2):222-9. PubMed ID: 23079136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of parathormone and alkaline phosphatase with bone turnover and mineralization in children with CKD on dialysis: effect of age, gender, and race.
    Soeiro EMD; Castro L; Menezes R; Elias RM; Dos Reis LM; Jorgetti V; Moysés RMA
    Pediatr Nephrol; 2020 Jul; 35(7):1297-1305. PubMed ID: 32157445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone biopsy results and serum bone turnover parameters in uremic children.
    Ziólkowska H; Pańiczyk-Tomaszewska M; Debiński A; Polowiec Z; Sawicki A; Sieniawska M
    Acta Paediatr; 2000 Jun; 89(6):666-71. PubMed ID: 10914959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Quality in Chronic Kidney Disease: Definitions and Diagnostics.
    McNerny EMB; Nickolas TL
    Curr Osteoporos Rep; 2017 Jun; 15(3):207-213. PubMed ID: 28447312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease: mineral and bone disorder in children.
    Wesseling-Perry K; Salusky IB
    Semin Nephrol; 2013 Mar; 33(2):169-79. PubMed ID: 23465503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphophonates in CKD patients with low bone mineral density.
    Liu WC; Yen JF; Lang CL; Yan MT; Lu KC
    ScientificWorldJournal; 2013; 2013():837573. PubMed ID: 24501586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.
    Hsu CY; Chen LR; Chen KH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy.
    Sabbagh Y; Graciolli FG; O'Brien S; Tang W; dos Reis LM; Ryan S; Phillips L; Boulanger J; Song W; Bracken C; Liu S; Ledbetter S; Dechow P; Canziani ME; Carvalho AB; Jorgetti V; Moyses RM; Schiavi SC
    J Bone Miner Res; 2012 Aug; 27(8):1757-72. PubMed ID: 22492547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective skeletal mineralization in pediatric CKD.
    Wesseling-Perry K
    Curr Osteoporos Rep; 2015 Apr; 13(2):98-105. PubMed ID: 25638580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the role of bone biopsy in the management of patients with CKD-MBD.
    Evenepoel P; Behets GJS; Laurent MR; D'Haese PC
    J Nephrol; 2017 Oct; 30(5):645-652. PubMed ID: 28831679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of bone biopsy for the diagnosis of renal osteodystrophy: a short overview and future perspectives.
    Carvalho C; Alves CM; Frazão JM
    J Nephrol; 2016 Oct; 29(5):617-26. PubMed ID: 27473148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorus Regulation in Chronic Kidney Disease.
    Suki WN; Moore LW
    Methodist Debakey Cardiovasc J; 2016; 12(4 Suppl):6-9. PubMed ID: 28298956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of bone microstructure, and treatment of bone fragility in chronic kidney disease.
    Seeman E
    Nephrology (Carlton); 2017 Mar; 22 Suppl 2():34-35. PubMed ID: 28429552
    [No Abstract]   [Full Text] [Related]  

  • 16. Value of the new bone classification system in pediatric renal osteodystrophy.
    Bakkaloglu SA; Wesseling-Perry K; Pereira RC; Gales B; Wang HJ; Elashoff RM; Salusky IB
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1860-6. PubMed ID: 20634327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Bone Histomorphometry after Kidney Transplantation.
    Keronen S; Martola L; Finne P; Burton IS; Kröger H; Honkanen E
    Clin J Am Soc Nephrol; 2019 Jun; 14(6):894-903. PubMed ID: 31088851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adynamic bone disease: from bone to vessels in chronic kidney disease.
    Bover J; Ureña P; Brandenburg V; Goldsmith D; Ruiz C; DaSilva I; Bosch RJ
    Semin Nephrol; 2014 Nov; 34(6):626-40. PubMed ID: 25498381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
    Pimentel A; Ureña-Torres P; Zillikens MC; Bover J; Cohen-Solal M
    Kidney Int; 2017 Dec; 92(6):1343-1355. PubMed ID: 28964571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Searching the optimal PTH target range in children undergoing peritoneal dialysis: new insights from international cohort studies.
    Haffner D; Schaefer F
    Pediatr Nephrol; 2013 Apr; 28(4):537-45. PubMed ID: 22893310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.